Technology (Nanotechnology, Nanoscience, Biomaterials, Biomechanics, Biomedical Engineering, Bioinformatics, Bioengineering, Biomedical Science) – Chen Immigration Blog https://www.wegreened.com/blog Specialized in National Interest Waiver (NIW) and Extraordinary Ability (EB1) Green Card Mon, 29 Aug 2022 08:14:58 +0000 en-US hourly 1 https://wordpress.org/?v=4.9.5 https://www.wegreened.com/blog/wp-content/uploads/2017/02/favicon-150x150.png Technology (Nanotechnology, Nanoscience, Biomaterials, Biomechanics, Biomedical Engineering, Bioinformatics, Bioengineering, Biomedical Science) – Chen Immigration Blog https://www.wegreened.com/blog 32 32 Success Stories: NAILG Helped a Research Associate Working in the Field of Biotechnology from Pakistan Obtain NIW Approval https://www.wegreened.com/blog/niw/success-stories-nailg-helped-a-research-associate-working-in-the-field-of-biotechnology-from-pakistan-obtain-niw-approval/ Tue, 23 Aug 2022 09:31:21 +0000 https://www.wegreened.com/blog/?p=18863  

Client’s Testimonial:

“At this time I want to thank team Wegreen for ultimate support, guidance, and timely processing of my case.Hope for the best outcome. I am very pleased to know about my approval and thankful to your entire team for your support, guidance, and prompt response. I will recommend your law firm to my colleagues and friends who are interested.”


On September 20th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Research Associate in the Field of Biotechnology (Approval Notice).


General Field: Biotechnology

Position at the Time of Case Filing: Research Associate

Country of Origin: Pakistan

Country of Residence at the Time of Filing: Pakistan

Approval Notice Date: September 20th, 2021

Processing Time: 11 months, 13 days


Case Summary:

Under the “National Interest Waiver” (NIW) provision for EB-2, an individual requires:

  • A proposed endeavor, holding substantial merit and national importance.
  • The foreign national must be in a position to advance the proposed endeavor.
  • The applicant must present evidence that the U.S. would benefit on balance to waive the job offer criteria for an EB-2.

Therefore, to lead our client (from Pakistan), holding a Ph.D. in biotechnology and genetic engineering, currently working as a research associate in the field of biotechnology, towards her NIW approval, we prepared a well-drafted petition packet which included:

  • Her proposed endeavor: to investigate plants and their natural secondary metabolites to develop novel treatments for drug-resistant infections and diseases.
  • Her impressive record of publications and citations: 5 peer-reviewed journal articles (2 of them first-authored) cited a total of 131 times according to Google Scholar.
  • Her review record: at least 2 reviews for at least 4 journals.
  • Recommendation letters: the fellow experts in the field have provided further detail on the importance of this endeavor to the United States as one out of four stated:

“… To maintain this global dominance, which not only benefits the American economy but also the health of American citizens … the United States must retain talented researchers like [client] who develop new, effective, and highly marketable biomedical materials that drive growth in the field and industry.”

Our client’s research thus has both substantial merit and national importance as it improves public health and advances the medical, biopharmaceutical, and agricultural sectors. Therefore, the adjudication judge granted our client her NIW petition approval despite waiting for a long time. We thank her for choosing our law firm and wish her good luck in her future endeavors.


]]>
Success Stories: A Researcher IV from Iran in Biomedical Science Gets NIW Approval in Less Than 3 Months with Our Help https://www.wegreened.com/blog/niw/success-stories-a-researcher-iv-from-iran-in-biomedical-science-gets-niw-approval-in-less-than-3-months-with-our-help/ Wed, 03 Aug 2022 07:55:00 +0000 https://www.wegreened.com/blog/?p=18795  

Client’s Testimonial:

“Thank you. I was very pleased to work with your law firm.”


On May 9th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher IV in the Field of Biomedical Science (Approval Notice).


General Field: Biomedical Science

Position at the Time of Case Filing: Researcher IV

Country of Origin: Iran

State of Residence at the Time of Filing: Alabama

Approval Notice Date: May 9th, 2022

Processing Time: 2 months, 17 days


Case Summary:

An expert in the field of biomedical science, our client hailed from Iran and held an M.D. degree. Her proposed endeavor was to continue using various methods informed by biomaterials engineering, animal surgery and imaging, fluorescent imaging, and gene and protein expression analysis in order to advance the development of translational materials and techniques and improve regenerative medicines and cancer treatments. She wanted us to help her file an NIW (National Interest Waiver) petition at USCIS. Given her excellent academic and professional career, our team was quick to recognize that her case had merit.

So we enjoined our team to find out more about her track record and then put these information pieces together for her petition packet. As was expected, they found that her research advancing her proposed endeavor is of great importance because it alleviates quality-of-life issues related to the diagnosis and treatment of some of the world’s deadliest and most widespread diseases. Furthermore, she has contributed substantially to the study of bone and cartilage tissue regeneration, with her efforts yielding progress in the use of grafting to treat conditions such as bone defects, osteoarthritis, and skin wounds. Thus we found that her cutting-edge research is paving the way for the development of effective treatments, therapies, and diagnostic procedures that vastly improve outcomes and quality of life for patients suffering from these health threats.

The process of filing was preceded by finding recommendations from other experts in the field. On our suggestion, she obtained 4 letters of recommendation in all, two coming from each dependent and independent source. Some excerpts from these letters are quoted below:

“[The client] has also provided a deeper understanding of the mechanisms behind the progression of ovarian cancer and its resistance to treatments. As ovarian cancer is the leading cause of gynecological cancer-related deaths, an expanded knowledge of the processes behind ovarian cancer provides researchers with the means to develop new treatments and therapies. Having continually proven herself to be especially proficient at the development of novel techniques to improve the efficacy of widely used and life-saving clinical treatments, there is a sustained and unremitting need for [client’s] continued contributions to biomedical science.”

“[The client] has a uniquely skilled ability to pinpoint and resolve major issues and shortcomings in contemporary medical practice, thereby identifying her as a vital asset to the American research community.”

These statements make clear how important her research is to the world. Her pioneering research into finding novel ways for effectively treating patients suffering from osteoarthritis and related issues is therefore beneficial to U.S. public health. In addition, her investigations into developing optimal therapeutics for use in treating cancer also directly align with U.S. efforts into combating this disease, which alone costs the country over $208 billion each year in medical expenditures. Her work targeting these major health threats has an enormous impact on the quality of life and standard of care for Americans suffering from them.

Parallelly, her research has resulted in 6 peer-reviewed scientific papers (1 of them first-authored). Not only this, but her research has also gone on to influence her peers. That is, these publications have been cited a total of 78 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of biomedical science.

Furthermore, her study has received funding from the NSF and the NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases. This funding supports projects with clearly-defined applications and substantial merit that advance healthcare initiatives and outcomes in the United States, with this underscoring the national value of her research.

It was thus no surprise to hear of her case approval. We are delighted to have been a part of this journey of hers.


]]>
Success Stories: An Indian Research Scientist Researching the Field of Biomedical Science Gets NIW as well as EB1A Approved, Despite a Long Wait https://www.wegreened.com/blog/eb1/success-stories-an-indian-research-scientist-researching-the-field-of-biomedical-science-gets-niw-as-well-as-eb1a-approved-despite-a-long-wait/ Thu, 23 Jun 2022 07:48:20 +0000 https://www.wegreened.com/blog/?p=18692  

Client’s Testimonial:

“Thank you for the great news and for your help in my case preparation for EB1A and EB2-NIW that led to their approval!”


On September 9th, 2021 and February 22nd, 2022, we received another EB2-NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approval for a Research Scientist in the Field of Biomedical Science (Approval Notice).


General Field: Biomedical Science

Position at the Time of Case Filing: Research Scientist

Country of Origin: India

State of Residence at the Time of Filing: Connecticut

Approval Notice Date: September 9th, 2021 (NIW) and February 22nd, 2022 (EB-1A)

Processing Time: 13 months, 12 days (NIW) and 14 months (EB-1A)


Case Summary:

One of the few leading experts on the mechanisms of gastrointestinal cancers like colorectal and pancreatic cancers in biomedical science, our client achieved a consistent and notable record of success and influence in these areas of study. She approached North America Immigration Law Group to help her in building an influential NIW (National Interest Waiver) petition, establishing that she is well-known for studying the mechanisms that drive colorectal and pancreatic cancers and has spent years investigating issues related to them and is regarded as an authority in the field of biomedical science.

Her impressive credentials ensured that we countersigned the client-attorney relationship agreement and proceeded with preparing a thorough petition dossier to achieve the national interest waiver for our remarkable client. We noted the following important aspects while filing her NIW case:

  • Peer review experience is considered to be a widely accepted method for research validation with publishers relying on the peer review process to uphold the quality and validity of individual articles and the journals that publish them. Therefore, she evaluated the work of her peers no fewer than 33 times.
  • In addition to directly advancing the study of the mechanisms of colorectal and pancreatic cancer through her original research and peer review service, she published 10 peer-reviewed scientific articles and 2 book chapters in international journals which attracted 424 citations from a wide audience hailing from well-known international institutions both in the United States and abroad.

    Not only did we assist her in devising this successful case but she also retained us for filing another petition under the I-140 EB1A (Alien of Extraordinary Ability) visa category. Even though both the visa categories are unique, we made sure to compile all the new information provided by our client to be incorporated in the EB1A petition to meet the requirements.

  • We observed that her research focuses on designing and executing research projects related to the discovery of novel therapeutic targets for treating pancreatic diseases which is relevant to improving the quality and cost-effectiveness of healthcare in the United States.
  • Her work has also been supported by funding from leading agencies, including the National Institute of General Medical Sciences (NIGMS), and the National Cancer Institute (NCI), another measure of her success in pursuing her proposed endeavor. Hence, these funding grants support foundational biomedical research to provide a basis for advances in a variety of medical domains.
  • Moreover, we included copies of her Ph.D. diploma and transcripts, the employment letter confirming her current position along with 4 recommendation letters acquired by our client from other established researchers in the field. One of them stated the below: –

“[Client’s] work significantly benefits the United States, where colorectal cancer is a highly prevalent and commonly deadly form of cancer. In fact, according to research from the United States Centers for Disease Control and Prevention, colorectal cancers are the 2nd most common cause of cancer-related death affecting both women and men. Because her work identifies new therapeutic targets for treating colorectal cancers, her work significantly benefits cancer outcomes in the United States. [Client’s] research is therefore in the clear interest of the United States. I thus offer her my full support in her continuation of her work in the field.”

Overall, we are glad that we were able to prove to the USCIS that our client is crucial for determining the mechanisms that drive colorectal cancer and is thus essential for addressing the root cause of the disease’s progression and reducing its prevalence in the United States. Thus, she received her NIW as well as EB1A despite a long wait. We truly thank her for her constant cooperation and kind support throughout the adjudication process.


]]>
Success Stories: Thanks to Premium Processing, a Chinese Research Scientist in Biomedical Science Gets EB1-A Approval in Just 8 Days https://www.wegreened.com/blog/eb1/success-stories-thanks-to-premium-processing-a-chinese-research-scientist-in-biomedical-science-gets-eb1-a-approval-in-just-8-days/ Tue, 21 Jun 2022 07:24:20 +0000 https://www.wegreened.com/blog/?p=18687  

Client’s Testimonial:

“Thank you so much for your efficiency and professionalism, my case was approved so smoothly. I am so glad to select Chen Immigration Team as my professional support for my green card application!”


On August 30th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Scientist in the Field of Biomedical Science (Approval Notice).


General Field: Biomedical Science

Position at the Time of Case Filing: Research Scientist

Country of Origin: China

State of Residence at the Time of Filing: Pennsylvania

Approval Notice Date: August 30th, 2021

Processing Time: 8 days (Premium Processing Requested)


Case Summary:

USCIS has laid out strict guidelines for the qualifying criteria under the EB1-A (Alien of Extraordinary Ability) category. This means that the petitioner needs to prove beyond reasonable doubt that their case has merit by showing that their work is valuable to the United States of America. This process can be both tiring and time-consuming for anyone who is unfamiliar with the system. This is where North America Immigration Law Group comes in. We help clients from all over the world to understand and remain ahead of the curve, leading them to certain success.

Last year in August a client from China came to us asking for help with his EB1-A case. He was an international postdoctoral associate working in the very competitive field of biomedical science. Armed with a Ph.D. in neuroscience, he wanted us to build a winning case for him. So our attorney suggested that he provide us with his updated CV and other relevant documents. Our team then took over and gleaned information about his academic and professional background.

We were able to find that he has spent years investigating issues related to neuroscience and ischemic stroke and is regarded as an authority in the field. The field has recognized his expertise by inviting him to review and evaluate the work of his peers a total of 25 times. These peer reviews were conducted for leading international journals in his field of expertise. Moreover, he has actively engaged his peers in the field of biomedical science by authoring and co-authoring 21 peer-reviewed scientific articles, and 1 book chapter that has been published in international journals. Due to its great applicability in the field, this research in biomedical science has been cited 391 times. This includes 323 citations according to Google Scholar and an additional 68 citations according to China National Knowledge Infrastructure (CNKI).

These citations of his publications have been cited by researchers in at least 35 countries according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of biomedical science.

On the other hand, his study has been supported by funding from the Spanish Ministry of Economy and Competitiveness (MINECO), the Flanders Fund for Scientific Research, COST Action, and the Miguel Servet Program. This support of his research, therefore, serves as evidence that his research is cutting-edge in the field and essential to public health. His study has also received funding from the National Institutes of Health. This funding supports medical research that fundamentally promotes public health in the United States. These institutions fund projects that promote scientific innovation and basic research aimed at improving society in general.

To further support his claim, we included excerpts from letters of support in their application, two of which are quoted below:

“In light of the substantial burden of Alzheimer’s disease on American citizens, research that helps to identify new, more effective treatments is clearly of great value to the U.S. By identifying a new source of safe, natural candidate drugs for the treatment of Alzheimer’s disease, [the client] has helped to enhance the country’s ability to reduce or prevent the development of Alzheimer’s disease.”

“Considering the profound impact that stroke has on both individuals and the United States healthcare system, [the client’s] research relating to the underlying mechanisms of stroke recovery and mediation is quite vital. His research aims to reduce the damage done during stroke events through uncovering novel therapies based on the molecular and cellular mechanisms triggered during strokes.”

All of this information put together made for an impressive application and we are happy to know of its approval in just 8 days. We wish him the best in all of his future endeavors.


]]>
Success Stories: We Fully Supported a Principal Scientist to Secure O1-A and EB1A Approvals in Just 14 Days and 9 days respectively, Thanks to Premium Processing Service Upgrade https://www.wegreened.com/blog/eb1/success-stories-we-fully-supported-a-principal-scientist-to-secure-o1-a-and-eb1a-approvals-in-just-14-days-and-9-days-respectively-thanks-to-premium-processing-service-upgrade/ Sat, 18 Jun 2022 08:06:51 +0000 https://www.wegreened.com/blog/?p=18678  

Client’s Testimonial:

“I am extremely grateful and my heartfelt thanks to The Chen Immigration Team. I am so happy to get my O1A & EB-1A approved in such a short term.”


On September 7th, 2021 and December 2nd, 2021, we received another O1-A (Individuals with Extraordinary Ability or Achievement) and EB-1A (Alien of Extraordinary Ability) approvals for a Principal Scientist in the Field of Nanoscience (Approval Notice).


General Field: Nanoscience

Position at the Time of Case Filing: Principal Scientist

Country of Origin: India

Country of Residence at the Time of Filing: India

Approval Notice Date: September 7th, 2021 (O1-A) and December 2nd, 2021 (EB1A)

Processing Time: 14 days (O1-A), and 9 days (EB1A) (Premium Processing Requested)


Case Summary:

A principal scientist based in India hired North America Immigration Law Group to help him obtain an O1-A (Individuals with Extraordinary Ability or Achievement) petition approval. Our law firm is well established for filing employment-based visa petitions uniquely which helps our clients to secure their ultimate goal; their green cards. Thus, before we began to prepare his O1A petition packet, we evaluated his credentials, therefore, we were certain that he would get the O1A approval. After 3 months of his O1A approval, our client retained us for another petition under the EB-1A (Alien of Extraordinary Ability) visa category. Normally, the O-1A visa is easier and quicker to get than an EB-1A green card. However, we helped our client to achieve both O-1A and EB1A approvals back-to-back in the gap of 3 months. We made sure to file a successful application in each category.

As we are aware that the O-1A visa is for individuals who have achieved national or international acclaim and have risen to the top of their field in the areas of science. The EB-1A enables individuals who have achieved substantial international or national success in their field due to their extraordinary talent to live permanently in the U.S. Since our client already held the O1A approval, it became way easier to obtain the EB1A success.

Here is the synopsis of his O1-A and EB-1A petition packets, containing the following details:

  • We briefed his research focusing on the development of silver nanowires, addressing some of our nation’s criticalities in understanding the underlying mechanisms of complex materials. Thus, his potent background in polymeric biomaterials science and engineering has enabled his research to be particularly successful, confirming him as a consistently productive researcher and among the top minds in the field of nanoscience today.
  • We incorporated his noteworthy publication and citation record; the 17 peer-reviewed scientific articles, two book chapters, and one monograph he published in top journals in the field. We concluded that peers have taken ample notice of our client’s work, having seen fit to cite it 1,386 times from 70 countries, this serves as a testament to its high quality and relevance to ongoing research.
  • Also, our client’s research is important for his field. He has established himself further in the field of nanoscience as a prolific peer reviewer. He has conducted 20 peer reviews for several journals, deducing his high regard as an authority in his field.
  • Moreover, we attached 4 recommendation letters provided by our client obtained from other experts in the field to establish that our client is at the forefront of the field of nanoscience as is demonstrated by this consistent record of success and his myriad professional accomplishments. One of the recommenders signed to:

“Considering his unparalleled success in the field of nanoscience thus far, I believe it is in the best interests of the scientific community and the United States that [client] be permitted to continue his research unimpeded.”

We’re delighted that our client found us, and we were able to help him secure the EB1A approval. Both O1A and EB-1A petitions are eligible for premium processing, which allows USCIS to decide on the filed petition within 15 days (whether it is “calendar” days or “business” days). Therefore, the O1-A case took 14 days to get approved after we filed his case. That said, the EB-1A has one of the shortest USCIS processing times, compared to other employment-based green cards. We are extremely happy that he successfully achieved his EB1A approval in just 9 days. We thank him for choosing our law firm to file his I-129 and I-140 petitions and again signing up for our services for his and his family’s I-485 applications.


]]>
Success Stories: A Research Associate from China Not Only Achieved EB1A Approval but also Obtained NIW Petition Approval 4 Months Apart with the Help of NAmILG https://www.wegreened.com/blog/eb1/success-stories-a-research-associate-from-china-not-only-achieved-eb1a-approval-but-also-obtained-niw-petition-approval-4-months-apart-with-the-help-of-namilg/ Mon, 30 May 2022 09:09:26 +0000 https://www.wegreened.com/blog/?p=18629  

Client’s Testimonial:

“I-140 approvals feel like the light at the end of the tunnel during this most difficult time. Thank you. Thank you. Thank you.”


On February 25th, 2021 and June 1st, 2021, we received another EB-1A (Alien of Extraordinary Ability) and EB-2 NIW (National Interest Waiver) approval for a Research Associate in the Field of Biomedical Science (Approval Notice).


General Field: Biomedical Science

Position at the Time of Case Filing: Research Associate

Country of Origin: China

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: February 25th, 2021 (EB-1A) and June 1st, 2021 (NIW)

Processing Time: 6 months, 23 days (EB-1A) and 11 months, 13 days (NIW)


Case Summary:

“Therefore, a better understanding of how to identify and effectively treat cancer at its point of origin has significant implications for the more than 1.8 million Americans diagnosed with the disease annually. It is clear that his studies directly address a major health issue and are beneficial to the United States as a whole.”

“This is of obvious value to the United States given that approximately 1 in 3 Americans will develop cancer throughout their lifetime. His studies ensure more effective treatment for those afflicted and lay the groundwork for further research in the field. Based on his substantial achievements and the importance of his studies to both his peers and to Americans as a whole, it is clear his work must be supported by the United States.”

The aforementioned 2 statements have been extracted from 2 of the 5 recommendation letters submitted by our client acquired from well-known researchers in the field of biomedical science.

Our client, a research associate holding a Ph.D. in biophysics, approached North America Immigration Law Group as he was certain that our law firm would definitely support him to achieve his NIW (National Interest Waiver) petition approval. As per our services, we advised our client to submit more evidence along with letters of support to further this case. Accordingly, after reviewing his credentials, undoubtedly, we were impressed and agreed to take his case forward to USCIS for further adjudication.

After we filed our client’s I-140 NIW petition, he retained our services to get one more petition filed under the I-140 EB1A (Alien of Extraordinary Ability) visa category. Since we had already worked on his NIW case, we affirmed articulating another petition on his behalf without any hesitance. We laid out unique structures in the respective cases and mentioned the following:

  • One of the foremost aspects we noted was his research on the role of receptor localization in human development and drug delivery and how it was crucial addressing some of the world’s most pressing issues, including cancer treatment, confirming that his research is relevant to improving drug delivery methods, therefore not only reducing the burden of cancer but also accelerating the production of drugs for cancer and other diseases, thereby benefiting the global pharmaceutical industry.
  • Moreover, we discussed the 126 citations accumulated from 5 peer-reviewed journal articles (3 first-authored) he published in some of the field’s leading publications, which are recognized for their high standards and wide international readership. There, his recurrent inclusion in such titles is a testament to his research’s saliency and high value. Ultimately, the approval of his research by the editors of these eminent journals is invaluable proof that he should be sponsored in the continuation of his research here in the United States. In addition, many other researchers have cited his study due to its value and practical research applications from at least 17 countries, thereby demonstrating that these publications are widely recognized and relied upon in the field of biomedical science.
  • Besides, we observed his excellence as a researcher in his repeated invitation by some of the leading publications in the field to conduct peer reviews and review manuscripts for publication. We specified that he has conducted 3 reviews, which is a distinct honor as the peer-review process is an integral factor of scientific publication that assists journal editors in maintaining the strict requirements and reputation of their periodicals. Overall, he has lent his knowledge and skills to many reviews, assisting in assuring the quality of articles published by several reputable journals.
  • Finally, we showcased that his research has also garnered the attention of major federal funding bodies. His work in this regard has received support from the National Science Foundation and the National Institutes of Health, indicating the immense value of his findings to issues of national importance. These are major funding bodies in the United States with a vested interest in work that addresses fundamental issues in medicine and scientific progress which further underscores the impact of our client’s research on the global scientific community within the United States.

Overall, we are super excited that our client allowed us to manage both of his I-140 petitions and be a part of this success story since he obtained his I-140 NIW and EB1A petitions approval 4 months apart. We are glad that once again our team’s efforts and diligence in both of our client’s cases paid off well. We would like to congratulate him as he advances in his chosen field, we also, sincerely thank him for associating with us not only for his I-140 petitions but for retaining our law firm for his I-485 applications as well.


]]>
Success Stories: We Helped a Biomedical Software Engineer from India in the Field of Bioinformatics to Achieve EB-1A Approval in Just a Month https://www.wegreened.com/blog/eb1/success-stories-we-helped-a-biomedical-software-engineer-from-india-in-the-field-of-bioinformatics-to-achieve-eb-1a-approval-in-just-a-month/ Sun, 22 May 2022 08:02:00 +0000 https://www.wegreened.com/blog/?p=18604  

Client’s Testimonial:

“Great, thanks. awesome news!! Thanks for all your help!”


On May 27th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Biomedical Software Engineer in the Field of Bioinformatics (Approval Notice).


General Field: Bioinformatics

Position at the Time of Case Filing: Biomedical Software Engineer

Country of Origin: India

Country of Residence at the Time of Filing: India

Approval Notice Date: May 27th, 2021

Processing Time: 1 month, 6 days (Premium Processing Requested)


Case Summary:

With an M.Sc. in bioinformatics and many years of experience attempting prescient research, there is no doubt that our client possesses the ability to advance in the field of bioinformatics. When he contacted our law firm to file an EB-1A (Alien of Extraordinary Ability) petition on his behalf, we delved more into his degrees and diplomas, and the employment letter confirming his current position before we agreed to take his case. After evaluating his credentials, we confirmed that we would lead him to EB1A success and countersigned the retainer agreement.

Our objective was to prove that he is a keystone researcher in the field of bioinformatics, therefore, we added pivotal attributes in his EB1A petition packet:

  • We noted the 833 times his work was cited by dependent and independent researchers, indicating the major significance of his findings to other biomedical software engineers around the world. Not only has he completed and published the results of his research in the field, but his findings have also influenced his counterparts. That is, his publications have been cited by researchers in at least 45 countries, thereby signifying that these publications are widely recognized and relied upon in the field of bioinformatics.
  • We also detailed the 29 peer-reviewed scientific articles he published, all of which appeared in some of the most discerning, high-impact journals in his field. Further, we listed the outstanding 10 times our client reviewed the work of his peers. As only the best in the field is invited to judge the work of others, our client’s noteworthy peer review record expressed the magnitude of his reputable status in the field.
  • We discussed one of the most important elements of our client’s EB1A petition which is related to his research on the utilization of analytics algorithms and open-source tools for analyzing biomedical data relating to cancer, and we concluded that his efforts address some of the country’s most pressing issues, including applying computational techniques and analytical tools to oncologic research, including cancer pathology, genomic biomarkers, and therapeutic efficacy.
  • To bolster our client’s case further, we added recommendation letters signed by six other expert scholars in the field, one of whom stated, “In sum, [client’s] novel research plays a critical role in advancing scientific knowledge towards addressing the challenges present in our current cancer treatment methods and drug therapies. His work has been recognized by both researchers and clinical practitioners, which speaks to its value to the field of bioinformatics and also to wider medical interests. His research continues to have an impact on the improvement of cancer treatments and targeted therapies, and therefore remains vital to medical research within the United States. I am thus pleased to recommend the continuation of his work in this country.”

We are pleased that our efforts and hard work, in this case, paid off well, and our client received his EB1A approval. We certainly moved him one big step closer to the green card process. We thank him for choosing North America Immigration Law Group to represent his EB1A case and for upgrading his case to premium processing service, which is a paid option offered by the USCIS that allows petitioners to enjoy accelerated adjudication, thus, his case secured the approval in just 1 month and 6 days. We wish him very well as he continues to advance in his chosen field.


]]>
Success Stories: An Assistant Scientist Achieves EB-1A and NIW cases Approval less than 2 Months apart, Now Awaits I-485 Approval With Us https://www.wegreened.com/blog/eb1/success-stories-an-assistant-scientist-achieves-eb-1a-and-niw-cases-approval-less-than-2-months-apart-now-awaits-i-485-approval-with-us/ Mon, 16 May 2022 08:30:10 +0000 https://www.wegreened.com/blog/?p=18591  

Client’s Testimonial:

“Thanks for letting me know about the NIW approval. It’s been a pleasure working with you. For someone with my profile, you guys helped me to get both NIW and EB1A approved. And I am working with you for I-485 for both me and my spouse. Meanwhile, I have already referred you to my friends and a few of them have already signed the contract with you and working. Thank you so much!”


On May 3rd, 2021 and June 16th, 2021, we received another EB-1A (Alien of Extraordinary Ability) and EB-2 NIW (National Interest Waiver) approval for an Assistant Scientist in the Field of Biomedical Science (Approval Notice).


General Field: Biomedical Science

Position at the Time of Case Filing: Assistant Scientist

Country of Origin: India

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: May 3rd, 2021 (EB-1A) and June 16th, 2021 (NIW)

Processing Time: 6 months, 9 days (EB-1A) (Premium Processing Requested) and 12 months (NIW)


Case Summary:

An assistant scientist contacted our law firm to help him establish his significant contributions to the U.S. by filing for an EB-2 NIW (National Interest Waiver) petition. We are obligated to evaluate our client’s qualifications and research backgrounds to certify the veracity of their credentials. So, after successfully checking his achievements, we submitted his NIW case to the USCIS. While his NIW petition was pending approval, he went through another notion that filing more than one petition at the same time can lead him to reach green card success sooner. Thus, he retained our services to construct another petition under the EB-1A (Alien of Extraordinary Ability) visa category. Since our priority was to present his exceptional professional background and unparalleled experience important to his current and future work to the USCIS, he is a uniquely valuable scientist who must be allowed to continue researching in the United States.

Thus, we added the following in his NIW and EB1A cases presentation to authenticate:

  • That he held a Ph.D. in biochemistry with extensive experience in researching the isolation and purification of genomic DNA, and native and denaturing electrophoresis techniques, among other molecular biology skills, as well as software skills. We concluded that his research addresses some of our nation’s most pressing issues, including understanding the molecular mechanisms that prevent cancer cells from apoptosis and the disrupting functions of proteins during cancer progression, which contribute to the development of improved cancer therapies.
  • Additionally, we highlighted the 241 citations piled up from 11 peer-reviewed scientific articles and 1 book chapter he published. He is an immensely impactful member of the field, as represented in his vast history of publications in prestigious and high-impact journals. Journal publications are the main means by which research findings are disseminated among the research community, so his consistent success in this domain is a sign of his prominence in the field. Moreover, his work is highly cited in at least 39 countries, demonstrating his work plays a major role in the advancement of research in biomedical science. Besides, he had also conducted 95 peer reviews for top research publications and journals, thereby confirming peer review activity is crucial to the scientific publication process and the academic community at large, and it is an instance of great and trustworthy information and skill within the given field. Hence, his peer review record is a final emphasis of his exceptional role within the field of biochemistry.
  • Also, we included five recommendation letters to bolster his case further, whereas his extraordinary influence in the field is discussed by his fellow experts, proving that he is a scientist who is central to the discipline and has conducted research that has benefits for the well-being of those with cancer around the world. Therefore, one of his recommenders stated the below-mentioned:

“Overall, [client] has contributed extensively both to the field of biomedical science and the health of the nation at large. These contributions firmly place him at the very top of the field and thus I strongly support his continued research in the United States.”

Our team’s efforts successfully paid off in conveying to the USCIS that our client’s expansive experience in the field of biomedicine has afforded him vast knowledge and formidable skills, which are a significant asset to any research setting and thus set him apart as a valuable researcher in the biomedicine field today. We would like to congratulate him for securing both I-140 approvals and retaining us for his I-485 as well. We truly wish him the best in all his future endeavors.


]]>
Success Stories: North America Immigration Law Group Helped a Chinese Postdoctoral Researcher in Bioengineering Get EB-1A Approval in a Short Period of 20 days (PP Requested) https://www.wegreened.com/blog/eb1/success-stories-north-america-immigration-law-group-helped-a-chinese-postdoctoral-researcher-in-bioengineering-get-eb-1a-approval-in-a-short-period-of-20-days-pp-requested/ Mon, 02 May 2022 07:41:56 +0000 https://www.wegreened.com/blog/?p=18545 On August 12th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Researcher in the Field of Bioengineering (Approval Notice).


General Field: Bioengineering

Position at the Time of Case Filing: Postdoctoral Researcher

Country of Origin: China

State of Residence at the Time of Filing: California

Approval Notice Date: August 12th, 2021

Processing Time: 20 days (Premium Processing Requested)


Case Summary:

“[The client’s] research is exciting because it offers a newly developed approach for siRNA delivery that utilizes nanocarriers. This approach optimizes cell treatment and achieves spatiotemporal control of gene silencing, making it a powerful method for stem cell research. In developing this new approach, [the client] has launched stem cell research into new levels for effective disease treatment and has indelibly contributed to not only the field of bioengineering but also the public health and economic fortitude of the United States.”

“In his fascinating research, [the client] has surmounted this challenge by bioengineering a new fungal biodetoxification method that yields maximal biomass hydrolysates, which are superior for the production of microbial lipids and biodiesel. In developing this biodetoxification method, [The client] has streamlined the use of biodiesel and promoted its positive impacts on the environmental and economic concerns of the United States.”

These are excerpts from the letters of recommendation that our client, a postdoctoral researcher working in the field of bioengineering who hails from China, obtained on our advice. These letters were supported by valuable information shared by him in his CV regarding his academic and professional background. We made sure that he qualified the clear language of the EB-1A (Alien of Extraordinary Ability) criteria before entering an attorney-client relationship with him. Given the strictures of USCIS, it became necessary to not only personalize the petition but also to make sure it contained information that swayed the adjudication in his favor. For this, we showcased his track record of publications, citations as well as funding, and peer review experience.

We showed that he has conducted at least 20 reviews for remarkable journals, the impact of which we outlined in detail.

His work has resulted in 9 peer-reviewed scientific articles (7 of them first-authored). Moreover, his papers have been published in some of the most discerning, high-impact journals in his field. And due to its great applicability in the field, his research in bioengineering has been cited 256 times in other peer-reviewed journal articles according to Google Scholar. These citations come from independent and leading researchers from well-regarded institutions and organizations around the world.

His study has also received funding from the National Institutes of Health and the Roche Translational & Clinical Research Center. This funding supports projects that directly benefit the public health and medical interests of the United States. Therefore, his research has clearly been recognized as nationally important.

Having enlisted his achievements, we waited for the adjudicating judge to come to their decision, which they did in a short period of 20 days only. Thanks to premium processing, the client received his EB-1A approval quickly. We are thankful to him for putting his trust in us.


]]>
Success Stories: North America Immigration Law Group Got 2 Cases Approved (NIW + I-485 ) for a Bangladeshi Postdoctoral Associate in the Field of Biomedical Science https://www.wegreened.com/blog/niw/success-stories-north-america-immigration-law-group-got-2-cases-approved-niw-i-485-for-a-bangladeshi-postdoctoral-associate-in-the-field-of-biomedical-science/ Tue, 19 Apr 2022 08:34:47 +0000 https://www.wegreened.com/blog/?p=18513  

Client’s Testimonial:

“We are so grateful and blessed to work with you. We thank you so much for your all help throughout our application. We wish your continuous success.”


On August 7th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the Field of Biomedical Science (Approval Notice).


General Field: Biomedical Science

Position at the Time of Case Filing: Postdoctoral Associate

Country of Origin: Bangladesh

State of Residence at the Time of Filing: Florida

Approval Notice Date: August 7th, 2021

Processing Time: 11 months


Case Summary:

With millions of patients only in the United States suffering from different varieties of cancer, the proposed endeavor of our client to continue investigation into understanding molecular mechanisms associated with altered cancer metabolism and metabolic dysfunction in child malnutrition and to identify common unknown metabolic liabilities correlating with tumor microenvironmental components in order to illuminate cancer metabolic dark matter and discover novel anti-cancer metabolic targets, immediately attracted our attention. So, when he wanted to file for an NIW (National Interest Waiver) and I-485, we helped him by customizing his application to USCIS.

North America Immigration Law Group specializes in NIW petitions and we have an impressive 25,000+ approval record. This gives us an edge in deciding the most suitable legal strategies depending on the client’s background. This is why after thoroughly checking the background information, we went ahead to help the client in filing a customized petition. We were able to get him an NIW approval in a relatively short period of 11 months. We made this possible by including some of the following information in the application.

  • That his research has resulted in 15 peer-reviewed journal articles (9 of them first-authored), and one first-authored book chapter. Moreover, these papers have been published in the top journals of this field. He has published these papers in no fewer than 6 highly ranked peer-reviewed journals.
  • His research has also gone on to influence his peers. That is, his publications have been cited a total of 162 times according to Google Scholar.
  • He has completed at least 5 peer reviews to date. Since only the most highly esteemed researchers in the field are invited to evaluate the work of their peers, especially in authoritative journals like these, his position as a preeminent scholar is clear.
  • In recognition of the value and importance of his work, his research has been granted funding by the NIH, Bankhead-Coley Cancer Research Program, James and Esther King Biomedical Research Program, and Florida Breast Cancer Research Foundation. These institutions are dedicated to addressing substantial public health concerns within the U.S.

This is why one of the independent advisory opinions, that we suggested him to obtain said the following about him:

“The benefits of [the client’s] research on the molecular mechanisms associated with altered cancer metabolism directly translates to positive patient outcomes for the millions of Americans afflicted with cancer.”

We thus wish him the best in all his future endeavors and we are assured that he will help progress the field in various novel ways. We are certain that his work would have a significant and tangible benefit to the national healthcare system, individual economic well-being, and national public health.


]]>